• 1
    Eisman JA 1999 Genetics of osteoporosis. Endocr Rev 20: 788804.
  • 2
    Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH 2001 A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107: 899907.
  • 3
    Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177182.
  • 4
    Giguère V, Yang N, Segui P, Evans RM 1988 Identification of a new class of steroid hormone receptors. Nature 331: 9194.
  • 5
    Bonnelye E, Merdad L, Kung V, Aubin JE 2001 The orphan nuclear estrogen receptor-related receptor alpha (ERRa) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153: 971983.
  • 6
    Tremblay GB, Kunath T, Bergeron D, Lapointe L, Champigny C, Bader JA, Rossant J, Giguere V 2001 Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes Dev 15: 833838.
  • 7
    Greschik H, Flaig R, Renaud JP, Moras D 2004 Structural basis for the deactivation of the estrogen-related receptor {gamma} by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J Biol Chem 279: 3363933646.
  • 8
    Giguere V 2002 To ERR in the estrogen pathway. Trends Endocrinol Metab 13: 220225.
  • 9
    Laganière J, Tremblay GB, Dufour CR, Giroux S, Rousseau F, Giguere V 2004 A polymorphic autoregulatory hormone response element in the human estrogen-related receptor alpha (ERRalpha) promoter dictates peroxisome proliferator-activated receptor gamma coactivator-1alpha control of ERRalpha expression. J Biol Chem 279: 1850418510.
  • 10
    Dequeker J, Tobing L, Rutten V, Geusens P 1991 Relative risk factors for osteoporotic fracture: A pilot study of the MEDOS questionnaire. Clin Rheumatol 10: 4953.
  • 11
    Freedman D, Lane D 1983 A nonstochastic interpretation of reported significance levels. J Busin Econ Statist 1: 292298.
  • 12
    Anderson MJ, Robinson J 2001 Permutation tests for linear models. Aust NZ J Stat 43: 7588.
  • 13
    Davison AC, Hinkley DV 1997 Bootstrap methods and their application. In: GillR, RipleyBD, RossS, SteinM, WilliamsD (eds.) Cambridge Series in Statistical and Probabilistic Mathematics, vol. 1. Cambridge University Press, Cambridge, MA, USA, p. 567.
  • 14
    Whitley E, Ball J 2002 Statistics review 1: Presenting and summarising data. Crit Care 6: 6671.
  • 15
    Black DM, Cooper C 2000 Epidemiology of fractures and assessment of fracture risk. Clin Lab Med 20: 439453.
  • 16
    Gluer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W, Blenk T, Armbrecht G, Stewart A, Clowes J, Thomasius FE, Kolta S 2004 Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: The OPUS Study. J Bone Miner Res 19: 782793.
  • 17
    Patel R, Blake GM, Jefferies A, Sautereau-Chandley PM, Fogelman I 1998 A Comparison of a Peripheral DXA System with Conventional Densitometry of the Spine and Femur. J Clin Densitom 1: 235244.
  • 18
    Deng HW, Li JL, Li J, Davies KM, Recker RR 1998 Heterogeneity of bone mineral density across skeletal sites and its clinical implications. J Clin Densitom 1: 339354.
  • 19
    Cetin A, Erturk H, Celiker R, Sivri A, Hascelik Z 2001 The role of quantitative ultrasound in predicting osteoporosis defined by dual X-ray absorptiometry. Rheumatol Int 20: 5559.
  • 20
    Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA 2003 Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res 18: 15311538.
  • 21
    Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, Baran DT 1996 Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J Endocrinol 134: 655659.
  • 22
    Suwanwalaikorn S, Van Auken M, Kang MI, Alex S, Braverman LE, Baran DT 1997 Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization. Am J Physiol 272: E212E217.
  • 23
    Milne M, Quail JM, Baran DT 1998 Dexamethasone stimulates osteogenic differentiation in vertebral and femoral bone marrow cell cultures: Comparison of IGF-I gene expression. J Cell Biochem 71: 382391.
  • 24
    Sass DA, Jerome CP, Bowman AR, Bennett-Cain A, Ginn TA, LeRoith D, Epstein S 1997 Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys. J Clin Endocrinol Metab 82: 12021209.
  • 25
    Lida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17: 808816.
  • 26
    Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T 1997 Expression of estrogen receptor beta in rat bone. Endocrinology 138: 45094512.
  • 27
    Milne M, Quail JM, Rosen CJ, Baran DT 2001 Insulin-like growth factor binding proteins in femoral and vertebral bone marrow stromal cells: Expression and regulation by thyroid hormone and dexamethasone. J Cell Biochem 26: 229240.
  • 28
    Tanko LB, Qin G, Alexandersen P, Bagger YZ, Christiansen C 2005 Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women. Osteoporos Int 16: 184190.
  • 29
    Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J, Scillitani A, D'Erasmo E, Minisola S 2004 Vitamin D status in female patients with primary hyperparathyroidism: Does it play a role in skeletal damage? Clin Endocrinol (Oxf) 60: 8186.
  • 30
    Suzuki Y, Davison KS, Chilibeck PD 2003 Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen. J Nutr Health Aging 7: 296299.
  • 31
    Pritchard JK, Stephens M, Donnelly P 2000 Inference of population structure using multilocus genotype data. Genetics 155: 945959.